AZISIGN 500 Tablet by Dr Precision is a high-quality oral antibiotic that contains 500 mg of Azithromycin, a potent macrolide antimicrobial agent designed to effectively combat a broad spectrum of bacterial infections. Specifically formulated for treating respiratory tract infections including pharyngitis, sinusitis, bronchitis, and community-acquired pneumonia, AZISIGN 500 also addresses skin and soft tissue infections such as impetigo, folliculitis, cellulitis, and infected wounds. Its effectiveness extends to otorhinolaryngological conditions including otitis media and other ENT infections, and it serves as a first-line therapy for sexually transmitted infections like uncomplicated urethritis and cervicitis caused by Chlamydia trachomatis. Manufactured under WHO-GMP and ISO-certified conditions by BluepillExpress, AZISIGN 500 guarantees premium pharmaceutical standards under the Dr Precision label. The tablet's pharmacokinetic advantages include a prolonged half-life of 68 hours and superior tissue penetration, facilitating once-daily dosing and shorter treatment courses, thereby enhancing patient compliance and treatment success rates. This product is also export-ready with full regulatory documentation and customizable private labeling options, making it an excellent solution for pharmaceutical companies, healthcare distributors, and marketing partners seeking a reliable, therapeutically effective macrolide antibiotic for global markets.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Azithromycin 500 mg |
| Antibiotic Class | Macrolide |
| Therapeutic Range | Respiratory, skin, ENT, and certain sexually transmitted infections |
| Dosage Form | Oral Tablet |
| Pharmacokinetics | Prolonged half-life of 68 hours enabling once-daily dosing |
| Bioavailability | High oral bioavailability with rapid absorption |
| Manufacturing Standards | WHO-GMP and ISO-certified |
| Regulatory Documentation | Full documentation available for global export |
| Customization | Private labeling options |
| Packaging | Tablet formulation ensuring consistent release |
| Attributes | Description |
|---|---|
| Brand | Dr Precision |
| Manufacturer | BluepillExpress |
| Strength | 500 mg |
| Dosage Form | Tablet |
| Indications | Respiratory tract infections, skin and soft tissue infections, ENT infections, select sexually transmitted infections |
| Mechanism of Action | Inhibits bacterial protein synthesis by binding to 50S ribosomal subunit |
| Half-life | Approx. 68 hours |
| Dosing Frequency | Once daily |
| Treatment Duration | Typically 3 to 5 days |
| Certifications | WHO-GMP, ISO |
| Availability | Globally exportable with regulatory documentation |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
AZISIGN 500 Tablet's broad spectrum activity against gram-positive, gram-negative, and atypical pathogens makes it effective for treating diverse bacterial infections found in both community-acquired and hospital settings.
Due to its prolonged half-life of approximately 68 hours, AZISIGN 500 requires only once-daily dosing and shorter treatment courses of 3 to 5 days, which significantly improves patient compliance and treatment adherence.
Yes, AZISIGN 500 is manufactured under WHO-GMP and ISO-certified standards with full regulatory documentation available, making it fully suitable for export in international pharmaceutical markets.
Yes, the product offers private labeling options, allowing pharmaceutical companies and marketing partners to rebrand AZISIGN 500 for distribution under their own labels.
High lipophilicity allows Azithromycin to concentrate in infected tissues and immune cells, maintaining effective drug levels even after plasma concentrations drop, thereby extending its antibacterial activity beyond dosing intervals.
AZISIGN 500 is primarily used as a first-line therapy for uncomplicated urethritis and cervicitis caused by Chlamydia trachomatis and is sometimes used in combination treatments for Neisseria gonorrhoeae.
The tablet formulation ensures excellent bioavailability and consistent drug release, leading to predictable absorption and clinical outcomes essential for effective infection management.
Country Of Origin: India
AZISIGN 500 Tablet is a premium-quality macrolide antibiotic containing Azithromycin 500 mg, formulated for the effective treatment of a wide range of bacterial infections. It is widely used to manage respiratory, skin, ear, and certain sexually transmitted infections. Manufactured by BluepillExpress under WHO-GMP and ISO-certified standards, AZISIGN 500 offers high bioavailability, once-daily dosing, and rapid therapeutic response. Its global export availability, coupled with full regulatory documentation and private labeling options, makes it an ideal choice for pharmaceutical companies, marketing partners, and healthcare distributors worldwide.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
AZISIGN 500 Tablet is a highly effective oral antibiotic formulation containing 500 mg of Azithromycin, an advanced macrolide-class antimicrobial agent used to treat various bacterial infections. Azithromycin is a widely recognized semi-synthetic derivative of erythromycin that functions by inhibiting bacterial protein synthesis through binding to the 50S ribosomal subunit. This mechanism halts bacterial growth, leading to the eventual elimination of the pathogen by the body’s immune system. AZISIGN 500 is a broad-spectrum antibiotic with activity against gram-positive, gram-negative, and atypical pathogens, making it suitable for both community-acquired and hospital-associated infections.
AZISIGN 500 is frequently prescribed for respiratory tract infections including pharyngitis, sinusitis, bronchitis, and community-acquired pneumonia. It is also highly effective in managing skin and soft tissue infections, ranging from impetigo and folliculitis to cellulitis and infected wounds. The drug is widely used in otorhinolaryngology for the treatment of otitis media and other ENT-related infections. Additionally, Azithromycin 500 mg is a first-line therapy in the management of certain sexually transmitted infections, including uncomplicated urethritis and cervicitis caused by Chlamydia trachomatis, and is occasionally used in combination therapies for Neisseria gonorrhoeae.
One of the major advantages of AZISIGN 500 Tablet lies in its pharmacokinetic superiority. With a prolonged half-life of 68 hours and excellent tissue penetration, Azithromycin ensures sustained drug levels in the body, allowing once-daily dosing and shorter course durations compared to other antibiotics. In many cases, a three-day or five-day course is sufficient, significantly improving patient compliance and treatment adherence. The high lipophilicity of Azithromycin allows it to concentrate in infected tissues and phagocytes, where it remains active even after plasma levels decline, thereby extending its therapeutic action.
The absorption of AZISIGN 500 is rapid following oral administration, with peak plasma concentrations reached within two to three hours. The drug’s unique pharmacological profile allows for significant concentrations in target tissues such as lungs, tonsils, and skin, which is critical in the management of infections involving these sites. The tablet formulation provides excellent bioavailability and consistent release, ensuring predictable clinical outcomes.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
